ライフサイエンスコーパス: acuity

1 herapy (average 4.6 lines gained on optotype acuity).

2 ILM flaps repaired FTMH and improved visual acuity.

3 ated movement of the eyeballs and for visual acuity.

4 coma are factors associated with poor visual acuity.

5 psychophysical measures of photopic spatial acuity.

6 h the off-center implant demonstrated 20/800 acuity.

7 European cohort with relatively good visual acuity.

8 urgical technique, complications, and visual acuity.

9 Research Database to larger ICUs with higher acuity.

10 hereas 2 eyes (4.4%) had worsening of visual acuity.

11 ed deficits in both binocularity and spatial acuity.

12 idual retinal slip and thus degraded dynamic acuity.

13 erning of the cone mosaic may improve visual acuity.

14 rrelated with both radiation dose and visual acuity.

15 while sparing response strength and spatial acuity.

16 thick myelination demanded for a keen visual acuity.

17 ent due to an asymmetric worsening of visual acuity.

18 rmeability on ICGA and improvement of visual acuity.

19 higher (p < 0.001) than for those with good acuity.

20 with decreased brain activity and cognitive acuity.

21 ion beyond the efforts to improve the visual acuity.

22 th corneal shape parameters than with visual acuity.

23 atial location of surface ridges with higher acuity.

24 r of perforation, scar size, or final visual acuity.

25 rted AEs had no significant impact on visual acuity.

26 tical coherence tomography (OCT), and visual acuity.

27 atient groups with different baseline visual acuities.

28 was calculated using recorded Snellen visual acuities.

29 n differences between GoCheck Kids and chart acuities (0.010) were not significantly different (P = .

30 mean differences between HOTV-ATS and chart acuities (0.084) were significantly different (P < .001;

31 ifference was found in best-corrected visual acuity (0.01 logarithm of the minimum angle of resolutio

32 hm of the minimum angle of resolution visual acuity (1.28 vs. 0.51, P < 0.001) (Snellen equivalent 20

33 82.2% eyes (37/45) had improvement in visual acuity, 13.3% (6/45) experienced no change, whereas 2 ey

34 mes smaller and concordant with mouse visual acuity(15).

35 03), with better median final Snellen visual acuity (20/30 vs. 20/70; not significant).

36 loaters (42.5%; n = 420), decrease in visual acuity (32.1%; n = 317), generalized eye pain (7.4%; n =

37 .6 mum, respectively, P = .066) or in visual acuity (66.5 +/- 14.3 and 68.9 +/- 14.5, respectively, P

38 of CME with concurrent improvement in visual acuity after an average of 6 weeks of therapy (range, 2-

39 Best-corrected visual acuity and central macular thickness were measured every

40 l apex had stronger correlations with visual acuity and contrast sensitivity than did subjects with a

41 and 2) CS as measured by the Freiburg Visual Acuity and Contrast Test (FrACT).

42 Daily use resulted in increasing sensory acuity and effectiveness in work and other activities of

43 ed with ischemia that correlated with visual acuity and radiation dose and may predict future develop

44 ple is the relationship between letter chart acuity and reading ability, as demonstrated by the diffe

45 Visual acuity and scar size were analyzed with multiple linear

46 measures included 3-week and 3-month visual acuity and scar size, corneal perforation, and/or the ne

47 isual impairment only assesses static visual acuity and static visual field despite many Paralympic s

48 photoreceptors would preserve central visual acuity and substantially improve patients' quality of li

49 Main outcome measures were change in visual acuity and the proportion of patients gaining 15 or more

50 Visual acuity and visual field impairments corresponding to Par

51 e (IOP), use of glaucoma medications, visual acuity, and complications were collected.

52 Review of culture results, visual acuity, and intraocular pressure also was performed for

53 PRIMA did not decrease the residual natural acuity, and it restored visual sensitivity in the former

54 omeMeasures: Rate of endophthalmitis, visual acuity, and microbial spectrum.

55 rated that older age, poorer baseline visual acuity, and presence of retinal angiomatous proliferatio

56 ychophysical work has suggested that the two acuities are strongly linked given that they both depend

57 TEMENT Abnormal binocular vision and reduced acuity are hallmarks of amblyopia, a disorder that affec

58 In summary, significant gains in visual acuity are seen after vitrectomy for diabetic TRD that c

59 hich clinicians round from highest to lowest acuity as determined by Sequential Organ Failure Assessm

60 The visual acuity as measured by the GoCheck Kids application was c

61 led ophthalmic examination, including visual acuity assessment and Scheimpflug imaging using the Pent

62 Visual acuity assessment and slit-lamp biomicroscopy were perfo

63 Mean logMAR visual acuity at presentation in cases that developed culture-p

64 Acuity-based rounding, in which clinicians round from hi

65 pic monocular best-corrected distance visual acuity (BCDVA; 4 m) and distance-corrected near visual a

66 ule complications were best-corrected visual acuity (BCVA) <=0.1 (decimal, adjusted odds ratio [aOR],

67 (r = -0.09; P < 0.001), best-correct visual acuity (BCVA) (r = -0.04; P < 0.001), flat K (r = -0.09;

68 regimen with regard to best-corrected visual acuity (BCVA) and brolucizumab achieving greater fluid r

69 tion was stratified by best-corrected visual acuity (BCVA) and hospital.

70 ion with assessment of best-corrected visual acuity (BCVA) and retinal imaging, including spectral-do

71 OP-lowering drugs, the best corrected visual acuity (BCVA) and the mean deviation (MD) of the perimet

72 with light perception best-corrected visual acuity (BCVA) and tractional retinal detachment (RD) in

73 Best-corrected visual acuity (BCVA) data, retinal imaging data, and clinical d

74 reatment, and a better best-corrected visual acuity (BCVA) during the first three months.

75 val], P value) gain in best-corrected visual acuity (BCVA) from baseline at Month 3 was 5.2 (12.2, [3

76 The best-corrected visual acuity (BCVA) improvement was 0.16 LogMAR for those with

77 tion in either eye and best-corrected visual acuity (BCVA) letter score of 49 letters or more (>=1 GA

78 ocular pressure (IOP), best corrected visual acuity (BCVA) logMAR and number of glaucoma medications

79 tment guided by either best-corrected visual acuity (BCVA) loss (Group I) or BCVA loss and/or signs o

80 degeneration (AMD) and best-corrected visual acuity (BCVA) of 20/80 to 20/800.

81 ere required to have a best-corrected visual acuity (BCVA) of 5 or more Early Treatment Diabetic Reti

82 measure was change in best corrected visual acuity (BCVA) over time.

83 Preoperative best corrected visual acuity (BCVA) showed and improvement from 0.4 +/- 0.4 Lo

84 Mean best-corrected visual acuity (BCVA) was stable; 3 implant-treated subjects wit

85 The mean change in best-corrected visual acuity (BCVA) with IVT-AFL from baseline to 24 months wa

86 elial cell loss (ECL), best-corrected visual acuity (BCVA), central corneal thickness (CCT), and comp

87 ular surgical history, best-corrected visual acuity (BCVA), intraocular pressure (IOP), clinical pres

88 lesion from the fovea, best-corrected visual acuity (BCVA), low-luminance BCVA, and low-luminance vis

89 Best-corrected visual acuity (BCVA), macular sensitivity, ellipsoid zone (EZ)

90 tests were scores for best-corrected visual acuity (BCVA); using the LogMAR scale, a multiparametric

91 ntly classic CNV (mean best-corrected visual acuity [BCVA], 48.2 letters at baseline) showed a higher

92 The neural circuitry that determines visual acuity begins in the retinal fovea, where the resolution

93 mes included best spectacle-corrected visual acuity (BSCVA) at 3 weeks and 3 months, percentage of st

94 lding times, best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), and graf

95 easures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endothelial

96 ere used for best spectacle-corrected visual acuity (BSCVA), spherical equivalent, hyperopic shift, a

97 We evaluated best spectacle-corrected visual acuity (BSCVA), topography, refraction, endothelial cell

98 ty (UDVA) or best spectacle-corrected visual acuity (BSCVA).

99 ging from V1 neurons revealed spared spatial acuity but impaired binocularity in L4 neurons.

100 utures (ROS), with corrected distance visual acuity (CDVA) >=20/40.

101 +/- 22.2 months), corrected distance visual acuity (CDVA) improved in 87.7% of all eyes and reached

102 preoperative mean corrected distance visual acuity (CDVA) was calculated in both groups.

103 acam), refraction, corrected distance visual acuity (CDVA), and glare CDVA was performed at 4 PM (aft

104 Change in corrected distance visual acuity (CDVA), severity scores of various ocular surface

105 rrected (UDVA) and corrected distance visual acuity (CDVA), subjective refraction, slit-lamp examinat

106 The following data were noted: visual acuity, central retinal thickness, distribution of fluid

107 Visual acuity, central subfield thickness, and adverse events a

108 he primary outcome was best-corrected visual acuity change (DeltaBCVA, logarithm of minimal angle of

109 ual acuity improvements and predicted visual acuity changes beyond what was explained by CST.

110 ive hemodynamic and metabolic milieu in high-acuity CLKT recipients increases delayed graft function

111 higher rates of astigmatism and worse visual acuity compared to all other races/ethnicities.

112 outcomes included corrected distance visual acuity, complications, and patient-reported outcomes mea

113 contrast sensitivity function (CSF [Freiburg acuity contrast test]), and quantitative B-scan ultrason

114 The primary outcomes measured were visual acuity, contrast and glare sensitivity (Pelli-Robson cha

115 mographic profile, clinical features, visual acuity, corneal topography, aberrometry, and biomechanic

116 cular distance-corrected intermediate visual acuity (DCIVA; 66 cm) and proportion of participants res

117 Distance-corrected near visual acuity (DCNVA) and subjective defocus curves up to +/-4.

118 DVA; 4 m) and distance-corrected near visual acuity (DCNVA; 40 cm) at 6 months after surgery.

119 The mean best-corrected visual acuity declined by 2 lines post-PED resolution.

120 Best-corrected visual acuity decreased from 20/25 to 20/40 Snellen equivalent

121 y and promotes functional recovery of visual acuity defects from amblyopia.

122 low-luminance BCVA, and low-luminance visual acuity deficit.

123 responses that reflect fatigue and temporal acuity deficits.

124 pment of normal binocular vision and spatial acuity depend upon experience-dependent refinement of di

125 source of referral and best-corrected visual acuity, diabetic retinopathy status in both eyes.

126 Residual natural acuity did not decrease after implantation in any patien

127 to 0.03), and mean corrected distance visual acuity difference was -0.01 logMAR (95% confidence inter

128 ure was not associated with decreased visual acuity, elevated intraocular pressure, or documentation

129 Main outcomes measured were visual acuity, endothelial cell count (ECC), rates of secondary

130 sed in a WT animal, axon function and visual acuity equilibrate between the two projections even when

131 The visual acuity equivalent (VAE), approximate Early Treatment Dia

132 an preoperative best-corrected logMAR visual acuity for all patients improved from 1.2 +/- 0.8 (20/31

133 ng modulates sensory processing and enhances acuity for discrimination of different sensory stimuli.

134 To measure visual acuity for Vernier offsets, we recorded evoked potential

135 outperformed them in correlating with visual acuity ([Formula: see text] compared to [Formula: see te

136 Main outcome measures included visual acuity, Foster stages, presence of extraocular involveme

137 ents to bring relevant information into high-acuity foveal vision.

138 Chart review examining visual acuities from patient visits before and after surgery, a

139 A comparison (final visual acuity, good vs. intermediate to poor) revealed a statis

140 One percent showed poor acuity (>=20/200) in the better-seeing eye, 12% in the w

141 patients, 49 (62%) demonstrated good visual acuity (>=20/40) and 30 (38%) showed intermediate to poo

142 % patients, even though final average visual acuity had improved.

143 from clinical practice found residual visual acuity impairment among all ages and races, especially a

144 Visual acuity improvement after MH surgery continued during the

145 d a significantly lower likelihood of visual acuity improvement following intravitreal bevacizumab tr

146 Primary study outcome was visual acuity improvement.

147 during follow-up was associated with visual acuity improvements and predicted visual acuity changes

148 al thickness, refraction, and (glare) visual acuity in advanced FECD.

149 lective Lypd6 overexpression restores visual acuity in amblyopic mice that underwent early long-term

150 than the right, along with decreasing visual acuity in both eyes following 3 months of PTX therapy fo

151 r of AGMs was 1 (IQR, 0-2) and median visual acuity in logarithm of minimum angle of resolutions (n =

152 -Darby canine kidney cells, highlighting its acuity in reconstructing both individual and collective

153 s are efficient treatment to maintain visual acuity in residual/recurrent DME after FAc.

154 escribed a significant improvement in visual acuity in the binocular group versus standard patching s

155 e donation improves axon function and visual acuity in the directly stressed region, it renders the d

156 specialisation for increased visual spatial acuity in the form of a horizontal streak of higher rod

157 stigmatism, spherical equivalent, low visual acuity in the worse seeing eye (>=1.3 logMAR), and cardi

158 To assess agreement between measurement of acuity, intraclass correlations with 95% confidence inte

159 l cell loss, best spectacle-corrected visual acuity, intraocular pressure, and glaucoma medications/s

160 ete ophthalmic examination, including visual acuity, IOP, slit lamp examination, and dilated fundusco

161 eived number but not the reverse, (3) number acuity is greatly reduced in stimuli controlled for perc

162 Improving or maintaining visual acuity is the main goal for the treatment of neovascular

163 se of foveal involvement, the loss of visual acuity lagged behind central RPE atrophy in AF images.

164 e pain, eyelid edema, poor presenting visual acuity, larger corneal ulcer diameter, and causative org

165 linking them with clinical outcomes (visual acuity, lesion activity and retinal morphology) using co

166 The mean visual acuity letter score over 24 weeks was 59.3 (Snellen equi

167 The mean visual acuity letter score was 52.6 (Snellen equivalent, 20/100

168 e, 57 [11] years; 115 [56%] men; mean visual acuity letter score, 34.5 [Snellen equivalent, 20/200]),

169 short-term results, with similar high visual acuity levels for both FECD and BK eyes.

170 cted distance, intermediate, and near visual acuities (logarithm of the minimum angle of resolution),

171 eyes was 1.1%, with at least moderate visual acuity loss in 0.14%.

172 cal measures of vision (low-luminance visual acuity, low-luminance deficit, and microperimetric sensi

173 The VFs were excluded if visual acuity <20/400 or loss of >=2 Snellen lines from baselin

174 30 (38%) showed intermediate to poor visual acuity (<=20/50) after PDT.

175 ved commonalities between letter and Vernier acuity may be due to common bottlenecks in early visual

176 The percentages of eyes with visual acuity measured by GoCheck Kids within 1 line of the HOT

177 is beneficial for patients with the highest acuity (MELD >=40), mortality in this group is high.

178 fety, and secondary outcomes included visual acuity, microperimetry and central retinal thickness.

179 delines to enroll patients, including visual acuity minimums, exclusion of bilateral eyes, sample siz

180 Rounding in decreasing order of patient acuity mitigated attrition in attentional reserves when

181 After surgery, all patients had visual acuities of 20/20 to 20/25.

182 ult's aged >=18 years with presenting Visual acuity of < 6/18 in the worst eye were considered as vis

183 itherapy and a best corrected Snellen visual acuity of 0.08.

184 f age, with a baseline best-corrected visual acuity of 2.3 to -0.2 logarithm of minimal angle of reso

185 eyes were more like to achieve final visual acuity of 20/20 to 20/40 (66% vs. 30%; P = 0.03), with b

186 etely attached, and 42 (69%) achieved visual acuity of 20/200 or better at last follow-up.

187 psia (100% vs. 0%; P = 0.04), initial visual acuity of 20/40 or better (77% vs. 23%; P < 0.001), mean

188 thalmology appointments (P = .045), a visual acuity of 20/40 or better (P = .027), and having Medicai

189 le glaucoma in one or both eyes and a visual acuity of 20/40 or better in each eye.

190 30 % of all patients regained a final visual acuity of 20/40 or better, while 31.2% had poor visual o

191 or blindness, an evaluated presenting visual acuity of 20/40 or worse in the better-seeing eye before

192 ement of the implant demonstrated prosthetic acuity of 20/460 to 20/550, and the patient with the off

193 Those with distance visual acuity of 6/12 or worse were refracted before near visua

194 Outside the fovea, array acuity of both OFF-midget and OFF-DB cells exceeds psych

195 ure as a number of factors limit the spatial acuity of functional voxels.

196 amically stable patients with sepsis and low acuity of illness may benefit from further work up befor

197 Students with visual acuity of less than or equal to 6/12 in the worse eye, w

198 The median visual acuity of patients with biopsy-negative MMP at presentat

199 hm of the minimum angle of resolution visual acuity of the whole cohort was 0.2 (0.5).

200 fferences in gender, BMI, % body fat, visual acuity or contrast sensitivity between those with and wi

201 ificant improvement of best-corrected visual acuity or macular edema.

202 Visual acuity outcomes vary; however, patients can recover exce

203 Visual acuity outcomes were better in eyes with no pre-existing

204 f similar types showed that trends in visual acuity outcomes were not inferior to those of ACIOL impl

205 not important factors in determining visual acuity outcomes.

206 quiring surgical management with poor visual acuity outcomes.

207 uding glaucoma severity, CS, age, and visual acuity (P = .004 better eye, P = .019 worse eye).

208 The overall 1-year survival of high-acuity patients improved from 69% in 2001 to 87% in 2016

209 Even with good central visual acuity, patients with glaucomatous macular damage exhibi

210 the CISS along with distance and near visual acuities plus non-cycloplegic autorefraction using a Shi

211 sion benefits most from the increased visual acuity provided by small pupils.

212 ation with patient care, measures of patient acuity, quality metrics, research database accuracy, and

213 s significantly associated with worse visual acuity (r = -0.24, P = .02), but SVC and ICP EAA were no

214 Correlations with acuity (r = 0.47) demonstrated construct validity.

215 The final Snellen visual acuity ranged from 20/20 to no light perception.

216 s to the futility of performing CLKT in high-acuity recipients.

217 m) was associated with higher odds of visual acuity recovery and maintenance (OR: 1.13; 95% CI: 1.03-

218 the CFs and contributes to impressive visual acuity recovery.

219 can complicate AMD and lead to severe visual acuity reduction.

220 Best-corrected visual acuity remained stable in both groups.

221 Even while central visual acuity remains relatively well preserved, GA often cause

222 order) versus novel (in decreasing order of acuity) rounding order.

223 an Failure Assessment score or an equivalent acuity score.

224 s with RVO demonstrating poor initial visual acuity showed visual and anatomic benefit with anti-VEGF

225 yes meeting target IOP, and change in visual acuity since the original trabeculectomy.

226 of surgical complications, changes in visual acuity, slit-lamp findings, and adverse events.

227 The median entering visual acuity (Snellen equivalent) was 20/40.

228 Visual acuity, spectral-domain (SD) OCT findings, injection det

229 s epithelial edema, and in all cases, visual acuity stabilized or improved following discontinuation

230 th high precision and briefly presented high-acuity stimuli at predefined foveal locations right befo

231 2 or worse were refracted before near visual acuity test.

232 ected underwent for distance and near visual acuity test.

233 ic assessment included best-corrected visual acuity testing, electrophysiologic examinations, and mul

234 Every patient received visual acuity testing, SD-OCT and slit lamp examination prior t

235 n in all subjects together, while for visual acuity the parameters were r = 0.30 (p < 0.01) for the h

236 ciated with a significant decrease in visual acuity, the presence of nonexudative MNV seems to be an

237 ents in the most common assessment of visual acuity, the Snellen eye chart.

238 gen-induced retinopathy model reduced visual acuity thresholds, reduced electroretinography amplitude

239 were managed medically and had stable visual acuity through their final visits (appETDRS score of 26

240 to control neuronal excitability and tactile acuity through tonic inhibition of thalamic neurons.

241 s were resolution of infection, final visual acuity, tolerance of miltefosine, and clinical course of

242 perative mean of uncorrected distance visual acuity (UDVA) divided by preoperative mean corrected dis

243 primary outcome was unaided distance visual acuity (UDVA) in the study eye at 3 months.

244 visual angle) of uncorrected distance visual acuity (UDVA) or best spectacle-corrected visual acuity

245 OutcomeMeasures: Uncorrected distance visual acuity (UDVA), best spectacle-corrected VA (BSCVA), mani

246 impossibility of restoring acceptable visual acuity using only medical treatments.

247 Course and prognosis are benign, visual acuity usually recovers.

248 Decreased visual acuity (VA) <6/12 was found in 12 of 135 eyes (8.9%) wit

249 avings achieved by eliminating formal visual acuity (VA) and dilated fundus examinations (DFEs) were

250 We evaluated relationships between visual acuity (VA) and eye-related quality of life and function

251 een first- and second-treated eyes by visual acuity (VA) and race/ethnicity and correlations between

252 Clinical data including visual acuity (VA) and visual fields (VFs) were collated from m

253 Microbiologic yield and corrected visual acuity (VA) at initial presentation and last follow-up (

254 Postoperative assessments included visual acuity (VA) at various distances under photopic and meso

255 Primary end point was visual acuity (VA) change from baseline to month 12.

256 y intensity and its relationship with visual acuity (VA) change in real-world neovascular age-related

257 The primary outcome was the change in visual acuity (VA) in the timely and delayed re-treatment group

258 Visual impairment was defined as visual acuity (VA) of > 0.3 logarithm of the minimum angle of r

259 lens (CL) vs intraocular lens (IOL), visual acuity (VA) outcome, and the need for surgery for visual

260 Three final outcomes were evaluated: visual acuity (VA) per eye (i.e., in the more severely affected

261 etic macular edema (CI-DME) with good visual acuity (VA) represent a controversial clinical scenario

262 disease status and to evaluate their visual acuity (VA) status.

263 wed up until they could perform chart visual acuity (VA) testing.

264 The mean +/- SD of the best-corrected visual acuity (VA) was 0.960 +/- 0.086 decimal, (range: 0.6-1),

265 Mean pre-endophthalmitis visual acuity (VA) was 20/64; mean VA at 6 months was 20/2069 (

266 Visual acuity (VA) was analyzed annually in completers (those w

267 Eyes grew 4.4 mm when visual acuity (VA) was better than 20/200, and 5.2 mm when VA w

268 stics, preoperative and postoperative visual acuity (VA), and MH status.

269 d included the baseline demographics, visual acuity (VA), and number of intravitreal injections.

270 e number of antiglaucoma medications, visual acuity (VA), and postoperative adverse events.

271 Demographic data, signs and symptoms, visual acuity (VA), fundus autofluorescence and OCT findings, E

272 Visual acuity (VA), intraocular pressure (IOP) and complication

273 Visual acuity (VA), refraction, stereoacuity, strabismus, ocula

274 rgical procedures, and best-corrected visual acuity (VA).

275 s (SOAS) of repair, and postoperative visual acuity (VA).

276 al amblyopia patients have asymmetric visual acuity (VA).

277 he impact of ocular (e.g., changes in visual acuity [VA], activity status, cataract surgery) and syst

278 on tests probed cones (best-corrected visual acuity [VA], contrast sensitivity), mixed cones and rods

279 visual impairment based on presenting visual acuity value was 2.4 +/- 0.7% using the World Health Org

280 iously, we showed that the evolution of high acuity vision in fishes was directly associated with the

281 ce Mask group (17.1 lines lost from baseline acuity vs 13.4 lines lost; P = .031), though no differen

282 The baseline mean visual acuity was 0.6 +/- 0.5 logarithm of the minimum angle of

283 en equivalent, 20/80), and the 7-year visual acuity was 0.8 +/- 0.6 logMAR (Snellen equivalent, 20/12

284 arithm of minimal angle of resolution visual acuity was 1.2 + 1.0.

285 arithm of minimal angle of resolution visual acuity was 1.7 +/- 0.8 and the average final logarithm o

286 thm of minimal angle of resolution of visual acuity was 1.89 +/- 0.71.

287 Upon examination, best-corrected visual acuity was 20/100 in the right eye and counting fingers

288 Best-corrected visual acuity was 20/50 or worse in 37.3% and 20/200 or worse i

289 Visual acuity was better in the subsequent eye at presentation

290 tion errors (SE) in the slabs and low visual acuity was established with a one-way ANOVA.

291 per placement of the chip, prosthetic visual acuity was only 10% to 30% less than the level expected

292 Visual acuity was significantly reduced in eyes with RRD at pre

293 -up period (P < .001); best-corrected visual acuity was similar at every time point to eyes that were

294 Visual acuity was taken using Snellens chart at 6 m.

295 Kids within 1 line of the HOTV-ATS and chart acuity were 65.3% and 86.7%, respectively.

296 in GA area, retardation of growth, or visual acuity were not demonstrated.

297 edictors for the worsening of DME and visual acuity when the treatment interval was extended to 8 wee

298 nt as needed resulted in less gain in visual acuity, whether instituted at enrollment or after 1 year

299 Impaired subjective morning visual acuity with improvement of symptoms during the day is pa

300 In 5 of 6 cases, visual acuity worsened with onset of bullous epithelial edema,